FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921995377> ?p ?o ?g. }

• W2921995377 endingPage "101042831983083" @default.
• W2921995377 startingPage "101042831983083" @default.
• W2921995377 abstract "The polymorphisms of invasion suppressor gene CDH1 and DNA mismatch repair gene Exo1 have been reported to play critical role in the development, tumorigenesis, and progression of several kinds of cancers including prostate cancer. This study was designed to analyze the contribution of single-nucleotide polymorphisms of the CDH1 (-160C/A) and Exo1 (K589E) to prostate cancer susceptibility in Bangladeshi population. The study included 100 prostate cancer cases and age-matched 100 healthy controls. Polymerase chain reaction-restriction fragment length polymorphism analysis was used to determine the genetic polymorphisms. A significant association was found between CDH1 -160C/A (rs16260) and Exo1 (rs1047840, K589E) polymorphisms and prostate cancer risk. In case of CDH1 -160C/A polymorphism, the frequencies of the three genotypes C/C,C/A, and A/A were 45%, 48%, and 7% in cases and 63%, 32%, and 5% in controls, respectively. The heterozygote C/A genotype and combined C/A + A/A genotypes showed 2.10-fold (odds ratio = 2.1000, 95% confidence interval = 1.2956–4.0905, p = 0.013) and 2.08-fold (odds ratio = 2.0811, 95% confidence interval = 1.1820–3.6641, p = 0.011) increased risk of prostate cancer, respectively, when compared with homozygous C/C genotypes. The variant A allele also was associated with increased risk of prostate cancer (odds ratio = 1.6901, 95% confidence interval = 1.0740–2.6597, p = 0.0233). In case of Exo1 (K589E) polymorphism, G/A heterozygote, A/A homozygote, and combined G/A + A/A genotypes were found to be associated with 2.30-, 4.85-, and 3.04-fold higher risk of prostate cancer, respectively (odds ratio = 2.3021, 95% confidence interval = 2.956–4.0905, p = 0.0031; odds ratio = 4.8462, 95% confidence interval = 1.0198–23.0284, p = 0.0291; OR = 3.0362, 95% confidence interval = 1.7054–5.4053, p = 0.0001, respectively). The “A” allele showed significant association with increased susceptibility (2.29-fold) to prostate cancer (odds ratio = 2.2955, 95% confidence interval = 1.4529–3.6270, p = 0.0004). Our results suggest that CDH1 -160C/A and Exo1 K589E polymorphisms are associated with increased susceptibility to prostate cancer in Bangladeshi population." @default.
• W2921995377 created "2019-03-22" @default.
• W2921995377 creator A5002616617 @default.
• W2921995377 creator A5004775388 @default.
• W2921995377 creator A5034128603 @default.
• W2921995377 creator A5040402582 @default.
• W2921995377 creator A5048036651 @default.
• W2921995377 creator A5058730881 @default.
• W2921995377 creator A5076419700 @default.
• W2921995377 creator A5083955476 @default.
• W2921995377 creator A5087020275 @default.
• W2921995377 date "2019-03-01" @default.
• W2921995377 modified "2023-10-17" @default.
• W2921995377 title "Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population" @default.
• W2921995377 cites W1532472949 @default.
• W2921995377 cites W1765439932 @default.
• W2921995377 cites W1903148213 @default.
• W2921995377 cites W1912879943 @default.
• W2921995377 cites W1963857144 @default.
• W2921995377 cites W1964212105 @default.
• W2921995377 cites W1968036595 @default.
• W2921995377 cites W1969235650 @default.
• W2921995377 cites W1974978671 @default.
• W2921995377 cites W1980634339 @default.
• W2921995377 cites W1981752846 @default.
• W2921995377 cites W1990348403 @default.
• W2921995377 cites W2004429375 @default.
• W2921995377 cites W2005815608 @default.
• W2921995377 cites W2005904571 @default.
• W2921995377 cites W2006824325 @default.
• W2921995377 cites W2011912935 @default.
• W2921995377 cites W2012195288 @default.
• W2921995377 cites W2019394964 @default.
• W2921995377 cites W2019570991 @default.
• W2921995377 cites W2019983958 @default.
• W2921995377 cites W2051620855 @default.
• W2921995377 cites W2054014866 @default.
• W2921995377 cites W2058963557 @default.
• W2921995377 cites W2061822389 @default.
• W2921995377 cites W2064262279 @default.
• W2921995377 cites W2065686472 @default.
• W2921995377 cites W2067412721 @default.
• W2921995377 cites W2068587729 @default.
• W2921995377 cites W2080562279 @default.
• W2921995377 cites W2088936376 @default.
• W2921995377 cites W2089415609 @default.
• W2921995377 cites W2090347206 @default.
• W2921995377 cites W2094725618 @default.
• W2921995377 cites W2105008109 @default.
• W2921995377 cites W2111049773 @default.
• W2921995377 cites W2112331024 @default.
• W2921995377 cites W2114903409 @default.
• W2921995377 cites W2116865857 @default.
• W2921995377 cites W2122439785 @default.
• W2921995377 cites W2122600066 @default.
• W2921995377 cites W2130128213 @default.
• W2921995377 cites W2131602976 @default.
• W2921995377 cites W2135002884 @default.
• W2921995377 cites W2135207730 @default.
• W2921995377 cites W2141798197 @default.
• W2921995377 cites W2161458293 @default.
• W2921995377 cites W2167518095 @default.
• W2921995377 cites W2170552969 @default.
• W2921995377 cites W2171854519 @default.
• W2921995377 cites W2172258686 @default.
• W2921995377 cites W2518950147 @default.
• W2921995377 cites W2570618306 @default.
• W2921995377 cites W4241386561 @default.
• W2921995377 cites W4248096216 @default.
• W2921995377 cites W82065600 @default.
• W2921995377 doi "https://doi.org/10.1177/1010428319830837" @default.
• W2921995377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30880589" @default.
• W2921995377 hasPublicationYear "2019" @default.
• W2921995377 type Work @default.
• W2921995377 sameAs 2921995377 @default.
• W2921995377 citedByCount "9" @default.
• W2921995377 countsByYear W29219953772019 @default.
• W2921995377 countsByYear W29219953772020 @default.
• W2921995377 countsByYear W29219953772021 @default.
• W2921995377 countsByYear W29219953772022 @default.
• W2921995377 countsByYear W29219953772023 @default.
• W2921995377 crossrefType "journal-article" @default.
• W2921995377 hasAuthorship W2921995377A5002616617 @default.
• W2921995377 hasAuthorship W2921995377A5004775388 @default.
• W2921995377 hasAuthorship W2921995377A5034128603 @default.
• W2921995377 hasAuthorship W2921995377A5040402582 @default.
• W2921995377 hasAuthorship W2921995377A5048036651 @default.
• W2921995377 hasAuthorship W2921995377A5058730881 @default.
• W2921995377 hasAuthorship W2921995377A5076419700 @default.
• W2921995377 hasAuthorship W2921995377A5083955476 @default.
• W2921995377 hasAuthorship W2921995377A5087020275 @default.
• W2921995377 hasBestOaLocation W29219953771 @default.
• W2921995377 hasConcept C104317684 @default.
• W2921995377 hasConcept C121608353 @default.
• W2921995377 hasConcept C126322002 @default.
• W2921995377 hasConcept C135763542 @default.
• W2921995377 hasConcept C143998085 @default.
• W2921995377 hasConcept C153209595 @default.

• next